These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31798726)

  • 1. An inventory of medicinal products causing skin rash: Clinical and regulatory lessons.
    Ancuceanu R; Dinu M; Furtunescu F; Boda D
    Exp Ther Med; 2019 Dec; 18(6):5061-5071. PubMed ID: 31798726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food-drug interactions in the summary of product characteristics of proprietary medicinal products.
    San Miguel MT; Martínez JA; Vargas E
    Eur J Clin Pharmacol; 2005 Apr; 61(2):77-83. PubMed ID: 15761758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.
    Weersink RA; Timmermans L; Monster-Simons MH; Mol PGM; Metselaar HJ; Borgsteede SD; Taxis K
    Front Pharmacol; 2019; 10():1031. PubMed ID: 31607904
    [No Abstract]   [Full Text] [Related]  

  • 5. Shaping medicinal product information: a before and after study exploring physicians' perspectives on the summary of product characteristics.
    Vromans L; Doyle G; Petak-Opel S; Rödiger A; Röttgermann M; Schlüssel E; Stetter E
    BMJ Open; 2013 Aug; 3(8):e003033. PubMed ID: 23965932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
    Ursino MG; Poluzzi E; Caramella C; De Ponti F
    Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF-α Inhibitors.
    Minnema LA; Giezen TJ; Hoekman J; Egberts TCG; Leufkens HGM; Gardarsdottir H
    Clin Pharmacol Ther; 2021 Jul; 110(1):123-131. PubMed ID: 33278830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information for adequate prescribing to older patients : an evaluation of the product information of 53 recently approved medicines.
    Beers E; Egberts TC; Leufkens HG; Jansen PA
    Drugs Aging; 2013 Apr; 30(4):255-62. PubMed ID: 23420118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Different number of contraindications between summaries of product characteristics (SmPC) of drugs with the same active ingredients - an analysis of data from SmPCs of neuropsychiatric drugs].
    Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
    Fortschr Neurol Psychiatr; 2020 Mar; 88(3):152-169. PubMed ID: 31127605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authorized or Off-Label Use? A Structured Analysis of Summaries of Product Characteristics with Regard to Authorization in Pediatrics.
    Herzig M; Eisenhofer S; Ruschkowski M; Neubert A; Bertsche A; Bertsche T; Neininger MP
    Pharmaceut Med; 2024 May; 38(3):205-216. PubMed ID: 38555544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.
    Arnardottir AH; Haaijer-Ruskamp FM; Straus SM; de Graeff PA; Mol PG
    Drug Saf; 2011 Nov; 34(11):1101-14. PubMed ID: 21981437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of summaries of product characteristics (SmPC) among family doctors and pharmacists in the context of the aut-idem regulation: Results of an exploratory cross-sectional survey].
    Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
    Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():45-53. PubMed ID: 32444219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances.
    Gahr M; Connemann BJ; Muche R; Zeiss R; Wolf A
    Eur J Clin Pharmacol; 2022 Mar; 78(3):419-434. PubMed ID: 34705065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports.
    Trippe ZA; Brendani B; Meier C; Lewis D
    Drug Saf; 2017 Apr; 40(4):293-303. PubMed ID: 28130773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines Agency.
    Orellana García LP; Ehmann F; Hines PA; Ritzhaupt A; Brand A
    Front Med (Lausanne); 2021; 8():753187. PubMed ID: 34790681
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicity Spectrum of Anti-GD2 Immunotherapy: A Real-World Study Leveraging the US Food and Drug Administration Adverse Event Reporting System.
    Wang G; Wang J; Du R; Wang Y; Li Z
    Paediatr Drugs; 2024 Mar; 26(2):175-185. PubMed ID: 38153627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials.
    Shimazawa R; Kano Y; Ikeda M
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00435. PubMed ID: 30455958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.